Review traces robotic esophagectomy outcomes and benchmarks using IDEAL framework

An Annals of Surgery review examines robotic-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer through the IDEAL framework for evaluating surgical innovation. It traces the technique from early implementation studies to comparative trials and international registry surveillance, covering postoperative complications, pain, quality of life and survival.

Early reports published in 2003 and 2006 described pulmonary complications in 48% of patients and mortality of 5%. Subsequent exploratory studies reported 48% five-year survival. Comparative trials, including the ROBOT trial, found better overall complication outcomes, pain scores and quality of life with RAMIE than with open surgery. Long-term follow-up showed no survival difference; the supplied text does not provide trial sample sizes or comparative effect estimates.

The Upper GI International Robotic Association registry, established in 2017, included 5,567 RAMIE cases from 58 sites worldwide by November 2025. Reported benchmarks included textbook outcome rates of 41–61%, leak rates of 11–16% depending on technique in the most recent cohort, and mortality below 4%.

These findings support RAMIE as an option at high-volume tertiary centers and inform surgical benchmarking. However, historical studies and contemporary registry results are not direct comparisons, and the supplied text does not define textbook outcome or detail risk adjustment. No long-term survival difference should not be interpreted as proof of oncological superiority.